Compound Summary
Compound Information
vigabatrin
Compound Name: | vigabatrin |
Compound CID: | 5665 |
Synonyms: | vigabatrin 4-aminohex-5-enoic acid 60643-86-9 Sabril 68506-86-5 More... |
Iupac Name: | 4-aminohex-5-enoic acid |
InChI: | InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9) |
InChIKey: | PJDFLNIOAUIZSL-UHFFFAOYSA-N |
Canonical Smiles: | C=CC(CCC(=O)O)N |
Isomeric Smiles: | C=CC(CCC(=O)O)N |
Molecular Weight: | 129.16 |
Molecular Formula: | C6H11NO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
vigabatrin
Molecular Weight: | 129.16 |
Molecular Formula: | C6H11NO2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 9 |
Complexity: | 112 |
Synonyms
vigabatrin
| vigabatrin | vigabatrin |
|---|---|
vigabatrin |
4-aminohex-5-enoic acid |
60643-86-9 |
Sabril |
68506-86-5 |
Vigabatrine |
gamma-Vinyl GABA |
4-Amino-5-hexenoic acid |
gamma-Vinyl-GABA |
Vigabatrinum |
5-Hexenoic acid, 4-amino- |
4-Aminohexenoic acid |
gamma-Vinyl-gamma-Aminobutyric Acid |
MDL-71754 |
GVG |
RMI-71754 |
CPP-109 |
CPP109 |
(+/-)-Vigabatrin |
(R,S)-4-Amino-5-hexenoic acid |
MDL 71,754 |
4-Amino-hex-5-enoic acid |
(+/-)-gamma-Vinyl-GABA |
CHEMBL89598 |
CHEBI:63638 |
Vigabatrine French |
Vigabatrinum Latin |
(+/-)-4-aminohex-5-enoic acid |
Vigabatrina Spanish |
VINYL GAMMA-AMINOBUTYRIC ACID |
MFCD00274577 |
NCGC00016087-06 |
Vigabatrina |
Sabrilex |
4-aminohex-5-enoic acid/S(+)-Gamma-VIGABATRIN |
gamma Vinyl GABA |
Sabril (TN) |
Vigabatrin USAN:INN:BAN |
MDL 71754 |
RMI 71754 |
Hexenoic acid, 4-amino |
SR-01000075653 |
(+-)-gamma-Vinyl GABA |
Kigabeq |
MFCD00274076 |
(1)-4-Aminohex-5-enoic acid |
CPP 109 |
Vigabatrin solution |
Prestwick_837 |
EINECS 270-929-6 |
CAS-60643-86-9 |
RMI-71890 |
.gamma.-vinyl GABA |
.gamma.-Vinyl-GABA |
Spectrum_000368 |
4-amino-5-hexenoicacid |
SpecPlus_000664 |
(y)-gamma-Vinyl GABA |
Prestwick0_000501 |
Prestwick1_000501 |
Prestwick2_000501 |
Prestwick3_000501 |
Spectrum3_001825 |
(?)-gamma-Vinyl GABA |
Biomol-NT_000247 |
V 8261 |
DSSTox_CID_21153 |
DSSTox_RID_79637 |
DSSTox_GSID_41153 |
Lopac0_001277 |
M071754 |
SCHEMBL26714 |
(+/-)-gamma-Vinyl GABA |
BSPBio_000421 |
BSPBio_003469 |
KBioSS_000848 |
Vigabatrin (JAN/USP/INN) |
(A+/-)-gamma-Vinyl GABA |
DivK1c_006760 |
SPECTRUM1502036 |
(+/-)-?-Vinyl GABA |
SPBio_002342 |
(+/-)-4-Aminohexenoic acid |
BPBio1_000465 |
BPBio1_000925 |
GTPL4821 |
DTXSID4041153 |
Vinyl .gamma.-aminobutyric Acid |
HSDB 8395 |
KBio1_001704 |
KBio2_000848 |
KBio2_003416 |
KBio2_005984 |
KBio3_002973 |
AMY6474 |
AOB6800 |
S(+)-4-AMINOHEXENOICACID |
HMS1569F03 |
HMS2094M21 |
HMS2096F03 |
HMS3263P16 |
BCP16220 |
Tox21_110301 |
Tox21_501277 |
BDBM50118886 |
AKOS015854596 |
ACN-036276 |
CCG-205350 |
CS-0791 |
DB01080 |
LP01277 |
SDCCGSBI-0051243.P004 |
.gamma.-Vinyl-.gamma.-aminobutyric acid |
NCGC00016087-03 |
NCGC00016087-04 |
NCGC00016087-05 |
NCGC00016087-07 |
NCGC00016087-08 |
NCGC00016087-09 |
NCGC00016087-11 |
NCGC00016087-22 |
NCGC00024802-02 |
NCGC00024802-03 |
NCGC00024802-04 |
NCGC00024802-05 |
NCGC00024802-06 |
NCGC00261962-01 |
AS-11778 |
HY-15399 |
SY263247 |
SBI-0051243.P003 |
( inverted question mark)-gamma-Vinyl GABA |
AB0010729 |
DB-117820 |
AB00053309 |
EU-0101277 |
FT-0675811 |
FT-0675812 |
FT-0700968 |
C07500 |
D00535 |
AB00053309_04 |
A853593 |
Q421663 |
Q-201924 |
SR-01000075653-1 |
SR-01000075653-4 |
SR-01000075653-6 |
( inverted exclamation markA)-4-aminohex-5-enoic acid |
BRD-A07893380-001-01-6 |
Z2235791448 |
Vigabatrin, European Pharmacopoeia (EP) Reference Standard |
Vigabatrin, United States Pharmacopeia (USP) Reference Standard |
Vigabatrin solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
Experimental Data
vigabatrin
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -4 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
vigabatrin
Statistics Data
vigabatrin
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -4 | 1 | 1 |
Statistics Data Visualization
vigabatrin
